Repository logo
 
Publication

PALOMA-3 clinical trial: is there a significant benefit in overall survival for breast cancer? Is it worth it?

dc.contributor.authorAdashek, Jacob J
dc.contributor.authorAguiar, Pedro N
dc.contributor.authorCastelo-Branco, Pedro
dc.contributor.authorLopes, Gilberto L
dc.contributor.authorDe Mello, Ramon Andrade
dc.date.accessioned2019-11-13T15:49:08Z
dc.date.available2019-11-13T15:49:08Z
dc.date.issued2019
dc.description.abstractBreast cancer is a very important disease in terms of public health worldwide. Several patients are diagnosed and follow to a progressive disease every year. CDK4/6 inhibitors (CDKi) were a paradigm shift in the treatment of hormone receptor-positive (HR+), HER2-negative advanced breast cancer (aBC).pt_PT
dc.description.sponsorshipAgência financiadora National Council for Scientific and Technological Development (CNPq) 402621/2016-6pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.2217/fon-2019-0044
dc.identifier.issn1479-6694
dc.identifier.urihttp://hdl.handle.net/10400.1/12884
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherFuture Medicinept_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectAntineoplastic combined chemotherapy Protocolspt_PT
dc.subjectBreast neoplasmspt_PT
dc.subjectClinical trials, Phase II as topicpt_PT
dc.subjectClinical Trials, Phase III as topicpt_PT
dc.subjectFemalept_PT
dc.subjectHumanspt_PT
dc.subjectTreatment outcomept_PT
dc.titlePALOMA-3 clinical trial: is there a significant benefit in overall survival for breast cancer? Is it worth it?pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage1410pt_PT
oaire.citation.issue13pt_PT
oaire.citation.startPage1407pt_PT
oaire.citation.titleFuture Oncologypt_PT
oaire.citation.volume15pt_PT
person.familyNameCastelo-Branco
person.familyNamede Mello
person.givenNamePedro
person.givenNameRamon Andrade
person.identifier.ciencia-idE015-7F8F-5CA1
person.identifier.orcid0000-0002-3453-3978
person.identifier.orcid0000-0002-9640-4573
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationbb25b5ad-1769-42be-a7d3-8fe76215aa23
relation.isAuthorOfPublication53ee625f-c5c3-468b-85bb-4cef5ad36928
relation.isAuthorOfPublication.latestForDiscoverybb25b5ad-1769-42be-a7d3-8fe76215aa23

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
fon-2019-0044.pdf
Size:
1.23 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.46 KB
Format:
Item-specific license agreed upon to submission
Description: